Warning letter
PharmScript, LLC: warning letter of Aug 23, 2017
FDA warning letter 535618 · New Jersey District Office
Key facts
| Reference number | 535618 |
|---|---|
| Company | PharmScript, LLC |
| Subject | Drug Product/Adulterated |
| Issue date | Aug 23, 2017 |
| Posted date | Dec 5, 2017 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| Inspection city | Somerset |
| Inspection ZIP | 08873 |
| Inspection start date | Oct 4, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: